United States Anti-Infective Drugs Market Report 2017

October 2017 | 106 pages | ID: U93FCFE5CACEN
QYResearch

Abstracts

In this report, the United States Anti-Infective Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anti-Infective Drugs in these regions, from 2012 to 2022 (forecast).

United States Anti-Infective Drugs market competition by top manufacturers/players, with Anti-Infective Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis AG
• Gilead Sciences
• Abbott
• Wyeth
• Sanofi-Aventis
• Bristol-Myers Squibb
• Johnson
• Roche Pharma AG
• Nanosphere
• NanoViricides
• Novabay Pharmaceuticals
• Obetech
• Optimer Pharmaceuticals
• Basilea Pharmaceutica AG
• Daiichi Sankyo
• MerLion Pharma
• Theravance

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibiotic Drugs
• Antiviral Drugs
• Antifungal Drugs
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Infective Drugs for each application, including

• Hospital
• Clinic
• Home
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anti-Infective Drugs Market Report 2017

1 ANTI-INFECTIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-Infective Drugs
1.2 Classification of Anti-Infective Drugs by Product Category
  1.2.1 United States Anti-Infective Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anti-Infective Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antibiotic Drugs
  1.2.4 Antiviral Drugs
  1.2.5 Antifungal Drugs
  1.2.6 Other
1.3 United States Anti-Infective Drugs Market by Application/End Users
  1.3.1 United States Anti-Infective Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home
  1.3.5 Other
1.4 United States Anti-Infective Drugs Market by Region
  1.4.1 United States Anti-Infective Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anti-Infective Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Anti-Infective Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anti-Infective Drugs Status and Prospect (2012-2022)
  1.4.5 New England Anti-Infective Drugs Status and Prospect (2012-2022)
  1.4.6 The South Anti-Infective Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Anti-Infective Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Infective Drugs (2012-2022)
  1.5.1 United States Anti-Infective Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Anti-Infective Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTI-INFECTIVE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anti-Infective Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Infective Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Infective Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Infective Drugs Market Competitive Situation and Trends
  2.4.1 United States Anti-Infective Drugs Market Concentration Rate
  2.4.2 United States Anti-Infective Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Infective Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTI-INFECTIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anti-Infective Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Infective Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Infective Drugs Price by Region (2012-2017)

4 UNITED STATES ANTI-INFECTIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anti-Infective Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Infective Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Infective Drugs Price by Type (2012-2017)
4.4 United States Anti-Infective Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTI-INFECTIVE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anti-Infective Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Infective Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTI-INFECTIVE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-Infective Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Anti-Infective Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Anti-Infective Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis AG
  6.4.2 Anti-Infective Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Gilead Sciences
  6.5.2 Anti-Infective Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Gilead Sciences Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.2 Anti-Infective Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Wyeth
  6.7.2 Anti-Infective Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Wyeth Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi-Aventis
  6.8.2 Anti-Infective Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi-Aventis Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bristol-Myers Squibb
  6.9.2 Anti-Infective Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bristol-Myers Squibb Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson
  6.10.2 Anti-Infective Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Roche Pharma AG
6.12 Nanosphere
6.13 NanoViricides
6.14 Novabay Pharmaceuticals
6.15 Obetech
6.16 Optimer Pharmaceuticals
6.17 Basilea Pharmaceutica AG
6.18 Daiichi Sankyo
6.19 MerLion Pharma
6.20 Theravance

7 ANTI-INFECTIVE DRUGS MANUFACTURING COST ANALYSIS

7.1 Anti-Infective Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Infective Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-Infective Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTI-INFECTIVE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anti-Infective Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Infective Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Infective Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Infective Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Infective Drugs
Figure United States Anti-Infective Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Anti-Infective Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotic Drugs Product Picture
Figure Antiviral Drugs Product Picture
Figure Antifungal Drugs Product Picture
Figure Other Product Picture
Figure United States Anti-Infective Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Infective Drugs by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Examples
Table Key Downstream Customer in Home
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Anti-Infective Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Infective Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Infective Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Anti-Infective Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Anti-Infective Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Infective Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anti-Infective Drugs Sales Share by Players/Suppliers
Figure United States Anti-Infective Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Infective Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Infective Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Infective Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Infective Drugs Revenue Share by Players/Suppliers
Table United States Market Anti-Infective Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Infective Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Anti-Infective Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anti-Infective Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Infective Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Infective Drugs Product Category
Table United States Anti-Infective Drugs Sales (K MT) by Region (2012-2017)
Table United States Anti-Infective Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Infective Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Infective Drugs Sales Market Share by Region in 2016
Table United States Anti-Infective Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Infective Drugs Revenue Share by Region (2012-2017)
Figure United States Anti-Infective Drugs Revenue Market Share by Region (2012-2017)
Figure United States Anti-Infective Drugs Revenue Market Share by Region in 2016
Table United States Anti-Infective Drugs Price (USD/MT) by Region (2012-2017)
Table United States Anti-Infective Drugs Sales (K MT) by Type (2012-2017)
Table United States Anti-Infective Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Infective Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Infective Drugs Sales Market Share by Type in 2016
Table United States Anti-Infective Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Infective Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Infective Drugs by Type (2012-2017)
Figure Revenue Market Share of Anti-Infective Drugs by Type in 2016
Table United States Anti-Infective Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Anti-Infective Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anti-Infective Drugs Sales (K MT) by Application (2012-2017)
Table United States Anti-Infective Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Infective Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Infective Drugs Sales Market Share by Application in 2016
Table United States Anti-Infective Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Infective Drugs Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Merck Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Merck Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Gilead Sciences Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Abbott Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Wyeth Basic Information List
Table Wyeth Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Wyeth Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Wyeth Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Wyeth Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Johnson Basic Information List
Table Johnson Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson Anti-Infective Drugs Sales Growth Rate (2012-2017)
Figure Johnson Anti-Infective Drugs Sales Market Share in United States (2012-2017)
Figure Johnson Anti-Infective Drugs Revenue Market Share in United States (2012-2017)
Table Roche Pharma AG Basic Information List
Table Nanosphere Basic Information List
Table NanoViricides Basic Information List
Table Novabay Pharmaceuticals Basic Information List
Table Obetech Basic Information List
Table Optimer Pharmaceuticals Basic Information List
Table Basilea Pharmaceutica AG Basic Information List
Table Daiichi Sankyo Basic Information List
Table MerLion Pharma Basic Information List
Table Theravance Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Infective Drugs
Figure Manufacturing Process Analysis of Anti-Infective Drugs
Figure Anti-Infective Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Infective Drugs Major Players/Suppliers in 2016
Table Major Buyers of Anti-Infective Drugs
Table Distributors/Traders List
Figure United States Anti-Infective Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Infective Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Infective Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Anti-Infective Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Infective Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources